PAVMEDLOGONEW15OCT2018.png
PAVmed Acquires EsophaCap Manufacturer CapNostics LLC
07 oct. 2021 11h41 HE | PAVmed Inc.
NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today...
Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of Directors
14 juin 2021 09h30 HE | PAVmed Inc.
NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today...
logo-alt.png
Global Intraosseous Infusion Device Market – Increasing number of surgical procedures, increasing research & development, and adoption of expansion strategies aresome of the major factors driving market growth - by PMI
24 déc. 2020 10h05 HE | PMI
Covina, CA, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Greater focus on designing automated intraosseous infusion devices is expected to offer lucrative growth opportunities for players in the global...
PAVMEDLOGONEW15OCT2018.png
PAVmed Adds EsoCure™ Esophageal Ablation Device with Patented Caldus™ Technology to Commercial Product Pipeline
18 févr. 2020 09h30 HE | PAVmed Inc.
Disposable single-use device designed to provide safer, more efficient and cost-effective ablation of dysplastic Barrett’s Esophagus, complementing Lucid Diagnostics’ EsoGuard™ and EsoCheck™ products ...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Hold Business Update Conference Call on May 21, 2019
06 mai 2019 09h30 HE | PAVmed Inc.
NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...